Study of the Functional State of the Left Ventricular Myocardium in Patients with Coronary Artery Disease with Impaired Metabolism of Homocysteine and Vitamin D
Abstract
To date, it has been established that in the progression of coronary artery disease (CAD) and its complications, an increase in the level of homocysteine and hypovitaminosis D are essential. However, medical publications do not adequately cover the study of the effects of hyperhomocysteinemia and vitamin D deficiency on the course of atherosclerosis and the functional state of the myocardium, and requires more detailed research of this problem.
Objective. To study the functional state of the myocardium depending on the degree of hyperhomocysteinemia and hypovitaminosis D in patients with CAD.
Materials and methods. The study analyzed data from 69 diagnosed with CAD. Depending on the degree of hyperhomocysteinemia and the level of vitamin D, patients were divided into 3 groups.
Results. In all patients, speckle-tracking echocardiography revealed a decrease in longitudinal and circular myocardial deformation. Patients with hyperhomocysteinemia and vitamin D deficiency had significantly lower myocardial deformity. Comparing the data of echocardiography, it was found that in patients of all three groups – no significant difference in hemodynamic parameters was found, despite the difference in the level of HC and vitamin D.
Conclusions. Hyperhomocysteinemia and hypovitaminosis D are risk factors for the development of CAD. It was revealed that the higher level of homocysteine and the pronounced deficiency of vitamin D, are associated with more pronounced changes in the functional state of the myocardium.
References
- Nykonenko OS, Chmul KO, Nykonenko AO, Osaulenko VV, Efimenko NF. Prognostic value of homocysteine and vitamin D for patients with ischemic heart disease and multifocal atherosclerosis. Zaporozhye medical journal. 2018;20(1):31–5. https://doi.org/10.14739/23101210.2018.1.121880
- Wang N, Chen C, Zhao L, Chen Y, Han B, Xia F, et al. Vitamin D and nonalcoholic fatty liver disease: Bi-directional Mendelian randomization analysis. EBioMedicine. 2018;28:187–93. https://doi.org/10.1016/j.ebiom.2017.12.027
- Moretti R, Caruso P, Dal Ben M, Conti C, Gazzin S, Tiribelli C. Vitamin D, homocysteine, and folate in subcortical vascular dementia and Alzheimer dementia. Front. Aging. Neurosci. 2017;9:169. https://doi.org/10.3389/fnagi.2017.00169
- Nikonenko AS, Chmul KO, Nikonenko AA, Osaulenko VV. [The contractive function of the myocardium of the LV in the disturbance of homocysteine metabolism in IHD patients]. Cardiovascular Surgery Herald. 2018;3:17–23. Russian.
- Aronov DM, Lupanov VP. [Atherosclerosis and coronary heart disease: some aspects of pathogenesis]. Ateroskleroz i Dislipidemii. 2011;1(2):46–54. Russian.
- Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D’Agostino RB, Gibbons R, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:S49–S73 https://doi.org/10.1161/01.cir.0000437741.48606.98
- Sherbak SG, Sarana AM, Makarenko SV, Kamiliva TA, Maximov AG. [Some genetical peculiarities of metabolism of homocysteine, folate, and nitric oxide as risk factors of ischemic heart disease]. Herald of the Northwestern State Medical University named after I.I. Mechnikov. 2016;8:123–30. Russian.
- Naumov AV, Danilchyk IV, Sarana YuV. [Three Ways of Homocysteine Remethylation]. Journal of the Grodno State Medical University. 2016;2(54):27–32. Russian.
- Naumov AV. Gomocistein. Mediko-biologicheskie problemy. Minsk: Professionalnye izdanija; 2013. Russian.
- Kostuchenko GI. [Hyperhomocysteinemia: Clinical Significance, Age Cheracteristics, Diagnosis and Correction]. Clinical gerontology. 2007;13(4):32–40. Russian.
- Skvortsov YuI, Korolkova AS. [Homocysteine as a risk factor of ischemic heart disease development (review)]. Saratov Journal of Medical Scientific Research. 2011;7(3):619–24. Russian.
- Fefelova EV, Tsybikov NN, Tereshkov PP, Sepp AV, Izmestyev SV. [Mechanism of Hypercoagulation at Experimental Hyperhomocysteinemia]. Tromboz, gemostaz i Reologia. 2015;4(64):27–30.
- Fefelova YeV, Izmestyev SV, Sepp AV. [Morphological changes in the myocardium due to the action of homocysteineа]. In: Major aspects of clinical and experimental medicine. Major aspects of clinical and experimental medicine: Proceedings of the Materials of the All-Russian Scientific and Practical Conference dedicated to the 60th anniversary of the Chita State Medical Academy; 2013 Oct. 17–18; Chita, Russia. Chita; 2013. p. 189–90. Russian.
- Alekhin MN. [Ultrasound Methods of Myocardium Strain Evaluation and Their Clinical Significance. Speckle Tracking in the Myocardium Strain and Torsion Evaluation (Lecture 2)]. Ultrasound and Functional Diagnostics. 2011;3:107–120. Russian.
- Miroshnyk M. [Vector Analysis of myocardial strain: a new path in cardiology]. Ukrainsko-frantsuzkyi visnyk. 2009;1:3–6. Ukrainian.
- Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, et al. Heart Disease and Stroke Statistics—2011 Update: a Report from the American Heart Association. Circulation. 2011 Feb 1;123(4):e18–e209. https://doi.org/10.1161/CIR.0b013e3182009701
- Marwick TH. Measurement of strain and strain rate by echocardiography: ready for prime time? J. Am. Coll. Cardiol. 2006;47(7):1313–27. https://doi.org/10.1016/j.jacc.2005.11.063
- Mor-Avi V, Lang RM, Badano LP, Belohlavek M, Cardim NM, Derumeaux G, et al. Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography. Eur. J. Echocardiogr. 2011;12(3):167–205. https://doi.org/10.1093/ejechocard/jer021
- Tkachenko SB, Beresten NF. [Doppler tissue myocardial examination]. Moscow;2006
